BHC

Bausch Health

• Dow Jones·6d ago

  *Bausch + Lomb: Board Will Be Comprised of 10 Directors

• Dow Jones·6d ago

  *Bausch + Lomb: Eduardo C. Alfonso, MD, and Steven H. Collis Appointed to the Board

• Dow Jones·12/09 15:39

  Bausch Health Initiated at Equal-Weight by Barclays

• Dow Jones·12/09 15:39

  Bausch Health Price Target Announced at $8.00/Share by Barclays

• Dow Jones·12/01 15:42

  Bausch Health Shares Up on Acquisition of Chinese Distribution Partner

• Dow Jones·10/30 15:15

  Bausch Health Shares Climb on 3Q Profit, Revenue Rise

• Dow Jones·10/29 20:14

  *Bausch 3Q >BHC

• Dow Jones·10/29 20:14

  *Bausch 3Q Rev $2.68B >BHC

• Dow Jones·10/29 20:14

  *Bausch Raises FY25 View To Rev $10.05B-$10.25B >BHC

• Dow Jones·10/29 11:25

  Bausch + Lomb Swings to Quarterly Loss, Though Revenue Rises

• Dow Jones·10/09 12:15

  Bausch Health Shareholders Approve Adoption of Poison Pill Plan

• The Wall Street Journal·09/21 09:30

  How the FDA Is Taking Aim at the Surreal World of TV Drug Ads

• Dow Jones·09/11 21:08

  *News On Durect Corp. (DRRX) Now Under BHC.T

• Dow Jones·08/15 19:06

  Carl Icahn's Son, Icahn Capital Portfolio Manager Exit Bausch Health Board

• Dow Jones·08/15 18:32

  *Bausch Health: Icahn Group Net Long Position Fell Below Specified Threshold >BHC